
23/09/2025
A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo metabolic and bariatric surgery (MBS) live longer and face fewer serious health problems, compared with those treated with GLP-1 receptor agonist medicines alone. Patients who had surgery lost more weig...